Remission of prediabetes via lifestyle intervention

Affiliations

¹ Department of Medicine and Population Health, Veterans Affairs New York Harbor Healthcare System, Division of Endocrinology, Diabetes and Metabolism, Grossman School of Medicine, New York University, New York, NY 10010, USA. Electronic address: michael.bergman@nyulangone.org.
² Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Grossman School of Medicine, New York University, New York, NY 10010, USA.

Comment

Michael Bergman et al. Lancet Diabetes Endocrinol. 2023 Nov.

. 2023 Nov;11(11):784-785.

doi: 10.1016/S2213-8587(23)00258-9. Epub 2023 Sep 25.

¹ Department of Medicine and Population Health, Veterans Affairs New York Harbor Healthcare System, Division of Endocrinology, Diabetes and Metabolism, Grossman School of Medicine, New York University, New York, NY 10010, USA. Electronic address: michael.bergman@nyulangone.org.
² Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Grossman School of Medicine, New York University, New York, NY 10010, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A, von Schwartzenberg RJ, Arreola EV, Hanson RL, Sancar G, Katzenstein S, Lange K, Preißl H, Dreher SI, Weigert C, Wagner R, Kantartzis K, Machann J, Schick F, Lehmann R, Peter A, Katsouli N, Ntziachristos V, Dannecker C, Fritsche L, Perakakis N, Heni M, Nawroth PP, Kopf S, Pfeiffer AFH, Kabisch S, Stumvoll M, Schwarz PEH, Hauner H, Lechner A, Seissler J, Yurchenko I, Icks A, Solimena M, Häring HU, Szendroedi J, Schürmann A, de Angelis MH, Blüher M, Roden M, Bornstein SR, Stefan N, Fritsche A, Birkenfeld AL. Sandforth A, et al. Lancet Diabetes Endocrinol. 2023 Nov;11(11):798-810. doi: 10.1016/S2213-8587(23)00235-8. Epub 2023 Sep 25. Lancet Diabetes Endocrinol. 2023. PMID: 37769677 Clinical Trial.